Eric Leifer
About
Eric Leifer is a scholar working on Cardiology and Cardiovascular Medicine, Complementary and alternative medicine and Statistics and Probability.
According to data from OpenAlex, Eric Leifer has authored 77 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Cardiology and Cardiovascular Medicine, 23 papers in Complementary and alternative medicine and 12 papers in Statistics and Probability. Recurrent topics in Eric Leifer's work include Heart Failure Treatment and Management (34 papers), Cardiovascular Function and Risk Factors (23 papers) and Cardiovascular and exercise physiology (23 papers). Eric Leifer is often cited by papers focused on Heart Failure Treatment and Management (34 papers), Cardiovascular Function and Risk Factors (23 papers) and Cardiovascular and exercise physiology (23 papers). Eric Leifer collaborates with scholars based in United States, Canada and United Kingdom. Eric Leifer's co-authors include Lawton S. Cooper, David J. Whellan, Christopher M. O’Connor, Ileana L. Piña, Jerome L. Fleg, Steven J. Keteyian, William E. Kraus, Dalane W. Kitzman, David S. Rendall and Stephen J. Ellis and has published in prestigious journals such as JAMA, Circulation and Journal of Clinical Oncology.
In The Last Decade
Eric Leifer
70 papers receiving 4.7k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Eric Leifer United States | 29 | 3.2k | 1.5k | 773 | 413 | 355 | 77 | 4.8k | ||
| Eduardo Núñez Spain | 37 | 3.1k 1.0× | 285 0.2× | 153 0.2× | 644 1.6× | 710 2.0× | 154 | 4.5k | ||
| Micha T. Maeder Switzerland | 35 | 3.4k 1.1× | 279 0.2× | 179 0.2× | 1.2k 3.0× | 1.1k 3.0× | 164 | 4.8k | ||
| Hans Rickli Switzerland | 40 | 4.0k 1.3× | 291 0.2× | 110 0.1× | 1.3k 3.1× | 1.6k 4.6× | 191 | 5.7k | ||
| Vasileios Panoulas United Kingdom | 37 | 2.1k 0.7× | 83 0.1× | 392 0.5× | 392 0.9× | 806 2.3× | 160 | 4.2k | ||
| Christian Zugck Germany | 34 | 2.5k 0.8× | 447 0.3× | 38 0.0× | 347 0.8× | 397 1.1× | 112 | 3.7k | ||
| M.D. Cheitlin United States | 27 | 3.1k 1.0× | 290 0.2× | 76 0.1× | 826 2.0× | 1.1k 3.0× | 250 | 4.0k | ||
| Billie‐Jean Martin Canada | 20 | 1.4k 0.5× | 320 0.2× | 47 0.1× | 234 0.6× | 546 1.5× | 59 | 2.3k | ||
| David L. Prior Australia | 45 | 5.2k 1.6× | 591 0.4× | 41 0.1× | 1.2k 2.9× | 748 2.1× | 171 | 6.5k | ||
| Antonello D’Andrea Italy | 46 | 6.4k 2.0× | 356 0.2× | 66 0.1× | 2.4k 5.7× | 1.1k 3.2× | 321 | 8.0k | ||
| Maya Guglin United States | 32 | 3.1k 1.0× | 159 0.1× | 67 0.1× | 802 1.9× | 1.3k 3.6× | 278 | 4.7k |
Countries citing papers authored by Eric Leifer
Since
Specialization
Citations
This map shows the geographic impact of Eric Leifer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Leifer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Leifer more than expected).
Fields of papers citing papers by Eric Leifer
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Eric Leifer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Leifer. The network helps show where Eric Leifer may publish in the future.
Co-authorship network of co-authors of Eric Leifer
This figure shows the co-authorship network connecting the top 25 collaborators of Eric Leifer. A scholar is included among the top collaborators of Eric Leifer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Leifer. Eric Leifer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Germanio, Clara Di, Valerie Durkalski‐Mauldin, Eric Leifer, et al.. (2025). Viral and Immune Factors Associated With COVID-19 Outcome in the C3PO Trial of Convalescent Plasma. The Journal of Infectious Diseases. 231(5). 1198–1209.
2.
Troendle, James, et al.. (2025). Sensitivity Analyses for Missing in Repeatedly Measured Outcome Data. Statistics in Medicine. 44(23-24). e70282–e70282.
3.
Lindsell, Christopher J., Matthew S. Shotwell, Kevin J. Anstrom, et al.. (2024). The statistical design and analysis of pandemic platform trials: Implications for the future. Journal of Clinical and Translational Science. 8(1). e155–e155.
4.
Martens, Michael J., et al.. (2024). Sequential monitoring of time-to-event safety endpoints in clinical trials. Clinical Trials. 22(3). 267–278.
5.
Eapen, Mary, Joseph H. Antin, Jakub Tolar, et al.. (2024). Long-term survival after unrelated donor marrow transplantation for aplastic anaemia after optimized conditioning regimen: a retrospective multicentre cohort study. EClinicalMedicine. 76. 102819–102819.
6.
O’Donnell, Paul V., Claudio G. Brunstein, Ephraim J. Fuchs, et al.. (2021). Umbilical Cord Blood or HLA-Haploidentical Transplantation: Real-World Outcomes versus Randomized Trial Outcomes. Transplantation and Cellular Therapy. 28(2). 109.e1–109.e8.
7.
Daubert, Melissa A., Eric Yow, Huiman X. Barnhart, et al.. (2021). Differences in NT‐proBNP Response and Prognosis in Men and Women With Heart Failure With Reduced Ejection Fraction. Journal of the American Heart Association. 10(10). e019712–e019712.
8.
Chouairi, Fouad, Michael Fuery, Clancy W. Mullan, et al.. (2021). The Impact of Depression on Outcomes in Patients With Heart Failure and Reduced Ejection Fraction Treated in the GUIDE-IT Trial. Journal of Cardiac Failure. 27(12). 1359–1366.
9.
Ezekowitz, Justin A., Wendimagegn Alemayehu, Andrew Grant, et al.. (2021). The Influence of Comorbidities on Achieving an N-Terminal Pro-B-Type Natriuretic Peptide Target: A Secondary Analysis of the GUIDE-IT Trial. ESC Heart Failure. 9(1). 77–86.
10.
Fuchs, Ephraim J., Paul V. O’Donnell, Mary Eapen, et al.. (2020). Double unrelated umbilical cord blood vs HLA-haploidentical bone marrow transplantation: the BMT CTN 1101 trial. Blood. 137(3). 420–428.
11.
Kureshi, Faraz, Eric Leifer, Tushar Acharya, et al.. (2020). Comparison of professional medical society guidelines for appropriate use of coronary computed tomography angiography. Journal of cardiovascular computed tomography. 14(6). 478–482.
12.
O’Connor, Christopher M., Mona Fiuzat, Hillary Mulder, et al.. (2019). Clinical Factors Related to Morbidity and Mortality in High-Risk Heart Failure Patients: The GUIDE-IT Predictive Model and Risk Score. European Journal of Heart Failure. 21(6). 770–778.
13.
Januzzi, James L., Tariq Ahmad, Hillary Mulder, et al.. (2019). Natriuretic Peptide Response and Outcomes in Chronic Heart Failure With Reduced Ejection Fraction. Journal of the American College of Cardiology. 74(9). 1205–1217.
14.
Felker, G. Michael, Tariq Ahmad, Kevin J. Anstrom, et al.. (2014). Rationale and Design of the GUIDE-IT Study. JACC Heart Failure. 2(5). 457–465.
15.
Saber, Wael, Jennifer Le Rademacher, Mikkael A. Sekeres, et al.. (2014). Multicenter Biologic Assignment Trial Comparing Reduced-Intensity Allogeneic Hematopoietic Cell Transplant to Hypomethylating Therapy or Best Supportive Care in Patients Aged 50 to 75 with Intermediate-2 and High-Risk Myelodysplastic Syndrome: Blood and Marrow Transplant Clinical Trials Network #1102 Study Rationale, Design, and Methods. Biology of Blood and Marrow Transplantation. 20(10). 1566–1572.
16.
Keteyian, Steven J., Eric Leifer, Nancy Houston-Miller, et al.. (2012). Relation Between Volume of Exercise and Clinical Outcomes in Patients With Heart Failure. Journal of the American College of Cardiology. 60(19). 1899–1905.
17.
Moak, Jeffrey P., Eric Leifer, Dorothy Tripodi, Saidi Mohiddin, & Lameh Fananapazir. (2011). Long-Term Follow-Up of Children and Adolescents Diagnosed with Hypertrophic Cardiomyopathy: Risk Factors for Adverse Arrhythmic Events. Pediatric Cardiology. 32(8). 1096–1105.
18.
O’Connor, Christopher M., David J. Whellan, Kerry L. Lee, et al.. (2009). Efficacy and Safety of Exercise Training in Patients With Chronic Heart Failure. JAMA. 301(14). 1439–1439.
19.
Ashikaga, Hiroshi, et al.. (2007). Transmural Dispersion of Myofiber Mechanics. Journal of the American College of Cardiology. 49(8). 909–916.
20.
Bradstock, K. F., David Gottlieb, Didier Blaise, et al.. (2002). Non-myeloablative allogeneic stem cell transplantation (NST) for metastatic melanoma: nondurable chemotherapy responses without clinically meaningful graft-vs-tumor (GVT) effects.. Blood. 100(11).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Eduardo Núñez Breakdown of academic impact, for papers by Micha T. Maeder Breakdown of academic impact, for papers by Hans Rickli Breakdown of academic impact, for papers by Vasileios Panoulas Breakdown of academic impact, for papers by Christian Zugck Breakdown of academic impact, for papers by M.D. Cheitlin Breakdown of academic impact, for papers by Billie‐Jean Martin Breakdown of academic impact, for papers by David L. Prior Breakdown of academic impact, for papers by Antonello D’Andrea Breakdown of academic impact, for papers by Maya Guglin